Veeva Systems (VEEV)
(Delayed Data from NYSE)
$221.32 USD
+4.30 (1.98%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $221.37 +0.05 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Price, Consensus and EPS Surprise
VEEV 221.32 +4.30(1.98%)
Will VEEV be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for VEEV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VEEV
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
VEEV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Veeva Systems (VEEV) Advances While Market Declines: Some Information for Investors
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
Why Is Veeva (VEEV) Down 3.5% Since Last Earnings Report?
Other News for VEEV
Veeva Systems Inc (VEEV) Stock Price Up 3.87% on Oct 16
Buy Rating for Veeva Systems: Leveraging Veeva Link’s Innovative Market Intelligence in Pharma
Project $1M Q3 '24: The Goal Is In Sight
TimesSquare U.S. Mid Cap Growth Strategy Q3 2024 Commentary
CrowdStrike strikes back as one of top software ideas in 2025: RBC